Clinical trial
European Trial About Effect of RimoNabant on Abdominal Obese Patients With…
NCT00412698 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00412698 |
|---|---|
| Title | European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia |
| Official title | A European Randomized, Parallel Group, Two-arm Placebo-controlled, Double-blind Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Abdominally Obese Patients With Dyslipidemia With or Without Other Comorbidities |
| Acronym | ETERNAL |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity, Dyslipidemias |
| Intervention type | Drug |
| Interventions | rimonabant, Placebo |
| Enrollment | 645 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Dec 18, 2006 |
| Last update posted | Dec 10, 2010 |
| Countries | Czechia, Finland, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Portugal, Slovakia, Sweden and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: